Heart Test Laboratories (NASDAQ:HSCS) Rating Reiterated by Ascendiant Capital Markets

Heart Test Laboratories (NASDAQ:HSCS)‘s stock had its “buy” rating restated by Ascendiant Capital Markets in a research note issued on Monday, Benzinga reports. They presently have a $15.00 price target on the stock. Ascendiant Capital Markets’ price target would indicate a potential upside of 391.80% from the stock’s current price.

Heart Test Laboratories Stock Up 2.0 %

Shares of NASDAQ:HSCS traded up $0.06 during midday trading on Monday, reaching $3.05. The company’s stock had a trading volume of 6,467 shares, compared to its average volume of 56,989. The stock has a fifty day moving average of $3.40 and a 200 day moving average of $6.57. Heart Test Laboratories has a twelve month low of $2.36 and a twelve month high of $52.00. The firm has a market capitalization of $2.00 million, a PE ratio of -0.06 and a beta of 3.13.

Heart Test Laboratories Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.